BEATMICRO

HeartBeam, Inc.

HealthcareMedical - Healthcare Information Services
$0.86
$0.00(+3.13%)
52W$0.54
$4.00
Updated May 7, 12:00 AM
RSI34
RS Rating7/99
Beta1.24
Volatility148%
F-Score1/9
Mkt Cap$34M
CONSOLIDATING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

CONSOLIDATING

HeartBeam, Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is weak (RS Rating: 7), showing significant lag compared to the market leaders. Earnings growth of 22% provides fundamental context to the price action. Investors should exercise caution due to high volatility (148% annualized), which requires wider risk management.

Relative Strength
7
out of 99
Lagging
Trend Score
2/4
Minervini Criteria
CONSOLIDATING
Risk (Beta)
1.24
vs S&P 500
ABOVE MKT
52W Position
9%
from 52W low
Near Low
Trend & Momentum Analysis

Trend Template (Minervini)

CONSOLIDATING2/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$1.16
50 SMA > 100 SMA$1.59
100 SMA > 150 SMA$1.55
150 SMA > 200 SMA$1.48

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$0.94-8.53%BELOW
50 SMA$1.16-25.91%BELOW
100 SMA$1.59-46.25%BELOW
150 SMA$1.55-44.61%BELOW
200 SMA$1.48-42.22%BELOW

Price Performance

1D+3.1%
1W-0.5%
1M-28.7%
3M-40.1%
6M-47.2%
YTD-64.8%
1Y-53.5%
3Y-26.2%
52-Week Trading Range9% from low
$0.86
52W Low$0.54
52W High$4.00

Technical Indicators

RSI (14)BEARISH
34.2
305070
VCP ScoreCOOL
5/10
Base depth: 114.5%

Risk Profile

Beta
1.24
52W Vol
148%
ATR
$0.10
Max DD (1Y)
-74%

Volume Analysis

Today
478.8K
50D Avg
1.66M
Vol Ratio
0.29x
Liquidity
ILLIQUID

Earnings Momentum

Q1'25-6%
$-0.18
Q2'25+21%
$-0.15
Q3'25+21%
$-0.15
Q4'25+22%
$-0.14
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:
3 Years:
TTM:

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:+15.07%

Stock Price CAGR

10 Years:-15.64%
5 Years:-28.84%
3 Years:-26.20%
1 Year:-53.48%

Return on Equity

10Y Avg:-175.4%
5Y Avg:-327.0%
3Y Avg:-456.1%
Last Year:-571.1%

Key Metrics

Market Cap$34M
Gross Margin
Net Margin
Piotroski F-Score1/9

Frequently Asked Questions

Is BEAT in an uptrend right now?

BEAT has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.

Is BEAT overbought or oversold?

BEAT's RSI (14) is 34. The stock is in neutral territory, neither overbought nor oversold.

Is BEAT outperforming the market?

BEAT has a Relative Strength (RS) Rating of 7 out of 99. BEAT is currently lagging the broader market.

Where is BEAT in its 52-week range?

BEAT is trading at $0.86, which is 21% of its 52-week high ($4.00) and 9% above its 52-week low ($0.54).

How volatile is BEAT?

BEAT has a Beta of 1.24 and 52-week volatility of 148%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.